期刊文献+

NT-proBNP水平与心功能分级及LVEF值的相关性 被引量:9

Correlation among NYHA cardiac function class,LVEF and NT-proBNP level
下载PDF
导出
摘要 目的:研究血浆N末端B型利钠肽前体(NT-proBNP)水平与心功能分级及左室射血分数(LVEF)的相关性,探讨NT-proBNP与主要不良心血管事件(MACE)发生率的关系。方法:选择不同心功能水平患者243例(心功能正常者40例,心功能NYHA分级I级46例,Ⅱ级57例,Ⅲ级58例,Ⅳ级42例),测定患者血NT-proBNP水平及LVEF,并分析NT-proBNP与心功能分级及LVEF的相关性;随访24个月观察NT-proBNP水平与MACE事件发生率的关系。结果:血浆NT-proBNP水平、MACE发生率随心功能分级增加而明显升高(P均=0.001);Spearman相关分析显示:NT-proBNP水平与心功能分级呈明显正相关(r=0.856,P〈0.01),与LVEF呈明显负相关(r=-0.601,P〈0.01);随着NTproBNP水平(0-4级)升高,患者MACE发生率明显升高(分别为20%、41.3%、,50.9%、63.8%、71.4%,P=0.001)。结论:N末端B型利钠肽前体与心功能分级及左室射血分数值之间具有较好的相关性,与MACE也有关系,对诊断及预后有重要价值。 Objective: To study the correlation among NYHA cardiac function class, left ventricular ejection fraction (LVEF) and N-terminal pro-brain natriuretic peptide (NT-proBNP) and relationship between NT-proBNP and incidence rate of major adverse cardiovascular events (MACE). Methods: A total of 243 patients with different degree cardiac function were selected, including 40 cases with normal cardiac function, 46 cases with NYHA cardiac function class Ⅰ, 57 cases with NYHA cardiac function class Ⅱ, 58 cases with NYHA cardiac function class Ⅲ and 42 cases with NYHA cardiac function class Ⅳ. Plasma NT-proBNP level and LVEF were measured and correlations a-mong NYHA cardiac function class, LVEF and NT-proBNP were analyzed; all subjects were followed up for 24 months to observe the relationship between plasma NT-proBNP level and incidence rate of MACE. Results: Plasma NT-proBNP level and incidence rate of MACE significantly rose along with NYHA cardiac function class increased, P = 0. 001 both; Spearman correlation analysis indicated that NT-proBNP level was positively correlated with NYHA cardiac function class (r = 0. 856, P〈0.01) and inversely correlated with LVEF (r = - 0. 601, P〈0.01) ; along with NT-proBNP level rose (0-4th class), incidence rate of MACE significantly increased (namely 20%, 41.3%, 50.9%, 63.8% and 71.4% respectively, P = 0. 001). Conclusion: NT-proBNP level is significantly correlated with NYHA cardiac function class and LVEF, and related with MACE incidence rate, which possesses important diagnostic and prognostic value.
出处 《心血管康复医学杂志》 CAS 2015年第6期617-620,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 利钠肽 心室功能 心力衰竭 Natriuretic peptide, brain Ventricular function Heart failure
  • 相关文献

参考文献10

  • 1Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain[J]. Nature, 1988, 332(6159):78- 81.
  • 2Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid meas- urement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med, 2002, 347(3) :161 - 167.
  • 3Gardner RS, Ozalp F, Murday AJ, et al. N - terminal pro - brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure [J]. Eur Heart J, 2003, 24 (19): 1735-1743.
  • 4Mair J, Hammerer-Leroher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure [J]. Clin Chem Lab Med, 2001, 39 (7), 571-588.
  • 5Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B- type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multieenter evaluation [J]. Am Heart J, 2002, 144 (5), 834-839.
  • 6余碧菁,郑伯仁,林敏瑜.床边检测N-末端脑利钠肽前体对心力衰竭的诊断价值[J].心血管康复医学杂志,2011,20(6):575-577. 被引量:5
  • 7Wang TJ, Larson MG, Levy D, et al. Plasma nartiuretic petide levels and the risk of cardiovascular events and death [J]. NEnglJ Med, 2004, 350 (7): 655 663.
  • 8Ng LL, Loke I, O'Brien RJ, et al. Plasma urotensin in human systolic heart failure [J]. Circulation, 2002, 106 (23) : 2877 - 2880.
  • 9Jernberg T, Lindahl B, Siegbahn A, et al. N - terminal pro - brain nartiretic piptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coro- nary artery desease [J]. J Am Coll Cardiol, 2003, 42 (11): 1909 - 1916.
  • 10Lee SC, Stevens TL, Sandberg SM, et al . The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure [J]. J Card Fail, 2002, 8 (3) : 149- 154.

二级参考文献9

  • 1邵乐文,韩阳,王战坤,孙坚.床边即时脑利钠肽检测对呼吸困难的诊断价值[J].中华心血管病杂志,2004,32(12):1123-1125. 被引量:30
  • 2李莉,李瑞杰,宋丽芬,王亚娟,葛利荣,王璐.运动康复改善老年慢性心衰患者心功能和生活质量的研究[J].心血管康复医学杂志,2006,15(4):315-318. 被引量:79
  • 3刘芳,王凤芝,张秀兰.肾上腺髓质素和脑利钠肽在慢性心力衰竭中的价值分析[J].中华心血管病杂志,2007,35(2):187-187. 被引量:2
  • 4Kawai K, Hata K, Takaoka H, et al. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated car- diomyopathy during beta-blocker therapy: a potential of hot- mone-guided treatment [J]. Am Heart J, 2001, 141 (6):925 -932.
  • 5Grzybowski J, Bilinska ZT, Janas J, et al. Plasma concentra tions of N-terminal atrial natriuretic peptide are raised in asymp tomatic relatives of dilated cardiomyopathy patients with left yen tricular enlargement [J] Heart, 2002, 88 (2): 191-192.
  • 6Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal de- fect [J]. Pediatr Int, 2003, 45 (3): 249-254.
  • 7Colan SD, Borow KM, Neumann A. Left ventricular end-sys- tolic wall stress-velocity of fiber shortening relation: a load-inde- pendent index of myocardial contractility [J]. J Am Coll Cardi oi, 1984, 4 (4): 715-724.
  • 8Bianciotti LG, de Bold AJ. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension [J ]. Cardiovase Res,2001, 49 (4): 808-816.
  • 9迪丽努尔.塔吉,阿布力米提.米吉提.心功能不全患者血浆N-末端脑钠肽前体及血清尿酸浓度的相关性[J].心血管康复医学杂志,2010,19(2):125-127. 被引量:6

共引文献4

同被引文献90

引证文献9

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部